Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-064981
Filing Date
2025-05-07
Accepted
2025-05-07 07:05:23
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amrn-20250331.htm   iXBRL 10-Q 1951663
2 EX-31.1 amrn-ex31_1.htm EX-31.1 12919
3 EX-31.2 amrn-ex31_2.htm EX-31.2 13595
4 EX-32.1 amrn-ex32_1.htm EX-32.1 14045
5 GRAPHIC img154156263_0.jpg GRAPHIC 285861
  Complete submission text file 0000950170-25-064981.txt   10189470

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20250331.xsd EX-101.SCH 1240572
73 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20250331_htm.xml XML 2057333
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21392 | Film No.: 25919237
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)